Details of Host Protein-DME Interaction (HOSPPI)
General Information of Drug-Metabolizing Enzyme (DME ID: DME0195) | |||||
---|---|---|---|---|---|
DME Name | Phosphodiesterase 5A (PDE5A), Homo sapiens | DME Info | |||
UniProt ID | |||||
EC Number | EC: 3.1.4.35 (Click to Show/Hide the Complete EC Tree) | ||||
Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome |
Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
---|---|---|---|---|---|
ICD Disease Classification 02 Neoplasms | |||||
ICD-11: 2C12 Liver cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Liver cancer | Moderate hypermethylation | |||
Interaction Name | DNMT-PDE5A interaction | ||||
The Methylation Level of Disease Section Compare with the Other Disease Section | Moderate hypermethylation p-value: 1.20E-02; delta-beta: 2.40E-02 | ||||
Description | DNA methyltransferase (DNMT) is reported to moderatly hyper-methylate the PDE5A gene, which leads to a moderatly decreased expression of the drug-metabolizing enzyme Phosphodiesterase 5A. As a result, the interaction between DNMT and PDE5A can moderatly affect the drug-metabolizing process of Phosphodiesterase 5A. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue adjacent to the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
DME methylation in tissue other than the diseased tissue of patients
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2C30 Melanoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Transcription-factor regulation | |||||
Octamer-binding protein 7 (POU3F2) | Melanoma | Repression | |||
Uniprot ID | |||||
Interaction Name | POU3F2-PDE5A interaction | [1] | |||
Studied Cell Lines | WM266.4, A375P, A375M2, Skeml28, Skmel24, Colo829, Skeml5, Skmel13, MEL-HO, 501mel and 4599 cell lines | ||||
Ensembl ID | |||||
Description | Octamer-binding protein 7 (POU3F2) is reported to repress the transcription of PDE5A gene, which leads to a decreased expression of the drug-metabolizing enzyme Phosphodiesterase 5A. As a result, the interaction between POU3F2 and PDE5A can repress the drug-metabolizing process of Phosphodiesterase 5A. | ||||
ICD-11: 2E06 Prostate cancer metastasis | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Prostate cancer metastasis | Significant hypomethylation | |||
Interaction Name | DNMT-PDE5A interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 1.15E-02; delta-beta: -3.36E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the PDE5A gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Phosphodiesterase 5A. As a result, the interaction between DNMT and PDE5A can significantly affect the drug-metabolizing process of Phosphodiesterase 5A. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD Disease Classification 05 Endocrine/nutritional/metabolic diseases | |||||
ICD-11: 5B81 Obesity | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Obesity | Significant hypomethylation | |||
Interaction Name | DNMT-PDE5A interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 2.57E-08; delta-beta: -3.56E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the PDE5A gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Phosphodiesterase 5A. As a result, the interaction between DNMT and PDE5A can significantly affect the drug-metabolizing process of Phosphodiesterase 5A. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
References | |||||
---|---|---|---|---|---|
1 | Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A. Cancer Cell. 2011 Jan 18;19(1):45-57. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.